arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

NewGenIvf Group Ltd

NIVF

$0.59 ▼ -0.23 (-27.87%) at close

5 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

NewGenIvf Group Ltd shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth -13.0% ↘

Op. Margin -226.9% ↘

ROIC -31.8% ↘

FCF / Share None

Trailing P/E —

Price / Book 0.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

5-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$4.73M

↓ -13.0% —

Net Income Profit after all expenses

$9.88M

↑ +1983.1% —

Operating Margin Operating profit as % of sales

-226.9%

↓ -962.5% 0th

FCF / Share Free cash flow per share

$2.81

↑ +11.0% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability

Returns ↓

Financial Health

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Revenue Growth YoY (%)	-13.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-263%)	5.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-28%)	-13.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-270%)	44.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+454%)	—
EPS Growth YoY (%)	N/M	N/M	341.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	N/M	N/M	-71.6% Weak Weak Year-over-year change in net income	N/M	—
FCF Growth YoY (%)	—	—	—	11.0% Fair Fair Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	-7.4% Weak Weak Compound annual revenue growth over 3 years	9.7% Fair Fair Compound annual revenue growth over 3 years	—	—	—
EPS CAGR 3Y (%)	545.1% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Operating Margin (%) (%)	-226.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1613%)	-21.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-242%)	0.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-95%)	6.7% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-55%)	4.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-68%)
Effective Tax Rate (%) (%)	—	50.7% Weak ↓ Weak Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	60.5% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	188.7% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	—	-9.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-180%)	2.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	7.7% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-36%)	-0.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-100%)
FCF Margin (%) (%)	-234.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-153.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-35.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	27.2% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	34.4% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	-1.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	15.85x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-14.10x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	3.52x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-2657.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Return on Invested Capital (%)	-31.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	54.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	0.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	28.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-32.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	13.7% Good Good Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	37.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+147%)	50.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+234%)	3.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	81.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+443%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Interest Coverage (x)	-17.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	0.91x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	7.19x Good Good Operating income divided by interest expense Optimal: > 5x	3.03x Fair Fair Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-758.62K	$-457.74K	$-54.10K	$-27.56K	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Revenue per Share (USD)	—	—	—	$10.32	$7.35
Basic EPS, GAAP (USD)	$214.73	$-4.41K	$3.53	$0.80	$0.00
Free Cash Flow per Share (USD)	—	—	—	$2.81	$2.53
Book Value per Share (USD)	$110.68	—	$7.36	$0.94	—
Tangible Book Value per Share (USD)	$21.68	—	$7.36	$0.94	—
Basic Weighted Avg Shares (shares)	46,009	119	30,757	575,930	560,000

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Working Capital (USD)	$5.02M	$452.39K	$1.34M	$-157.03K	—
Total Equity (USD)	$26.63M	$-1.05M	$3.74M	$563.11K	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗
Sales/Revenue/Turnover (USD)	$4.73M	$5.43M	$5.14M	$5.94M	$4.12M
Depreciation Expense (USD)	$188.11K	$19.50K	$31.17K	$100.53K	$166.71K
Net Income, GAAP (USD)	$9.88M	$-524.64K	$130.19K	$458.67K	$-533.00
Operating Cash Flow (USD)	$-10.93M	$-8.26M	$-1.77M	$1.71M	$1.43M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 5 years · 4 quarters

NewGenIvf Group Ltd

Analytical Summary

5-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NIVF with peers